Phase II trial of utidelone as monotherapy or in combination with capecitabine in heavily pretreated metastatic breast cancer patients

BACKGROUND: The treatment of metastatic breast cancer (MBC) remains a great clinical challenge as drug resistance frequently develops. Alternative agents that can overcome drug resistance would offer new therapeutic options. The primary aim of this phase II study was to evaluate the efficacy and saf...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Hematol Oncol
Hauptverfasser: Zhang, Pin, Tong, Zhongsheng, Tian, Fuguo, Wang, Yongsheng, Yang, Junlan, Li, Weilian, Di, Lijun, Liu, Wei, Tang, Li, Qiu, Rongguo, Xu, Binghe
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2016
Schlagworte:
Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4982136/
https://ncbi.nlm.nih.gov/pubmed/27516093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-016-0297-7
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge